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Abstract
In vivo adipose tissue regeneration by preadipocytes was evaluated by combining them with collagen
sponges with different biodegradabilities and gelatin microspheres incorporating basic fibroblast growth fac-
tor (bFGF) for the controlled release. The collagen sponge biodegradability was regulated from 1–4 weeks
by changing the cross-linking conditions in collagen sponge preparation. The time profile of bFGF release
was controlled from 1–5 weeks by the biodegradability of gelatin microspheres used. The collagen sponges
combined with human preadipocytes and gelatin microspheres incorporating bFGF were implanted into the
back subcutis of nude mice to evaluate the adipose tissue regeneration. The regeneration of adipose tissue
was observed in every collagen sponge. The area of regenerated adipose tissue was maximal in the collagen
sponge with a degradation time of 2 weeks. No influence of the time profile of bFGF release on the area of
regenerated adipose tissue was detected.
© Koninklijke Brill NV, Leiden, 2010
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1. Introduction
In the reconstruction surgery of adipose tissues for the treatments of breast or sub-
cutaneous adipose tissue defects, the grafting of autologous semi-liquid free fat
tissue of a few millimeters in size has been clinically performed [1, 2]. However,
this therapy often meets some problems, such as the absorption and fibrosis of tis-
sues grafted [3–5]. As one trial to tackle the problems, it is important to artificially
induce de novo formation of adipose tissue at the defect site, which will be a promis-
ing therapeutic substitute for the tissue graft.
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Recently, tissue engineering has been being noticed as a newly emerging biomed-
ical technology to repair or regenerate body defects by combining stem or precursor
cells with their scaffolds and growth factors [6, 7]. There are two possible strate-
gies based on tissue engineering to induce de novo adipogenesis. The first strategy
is to make use of cells with high potentials for proliferation and differentiation to
achieve cells-induced regeneration of adipose tissues. The cells are transplanted
into a body site where de novo formation of adipose tissue is expected. For exam-
ple, it is reported that a cell line of preadipocytes induced the formation of adipose
tissue at the subcutaneous site injected in nude mice [8]. This strategy is practi-
cally applicable for regeneration of fat tissues, and some trials have been reported
[9–12]. Patrick et al. have succeeded in the formation of adipose tissues in the rat
subcutis by use of porous scaffold of poly(lactic-co-glycolic acid) pre-seeded with
preadipocytes autologously isolated [10, 13]. Adipose tissue engineering using a
collagen scaffold combined with human preadipocytes has also been reported [11,
14]. We have demonstrated adipose tissue regeneration by the subcutaneous im-
plantation of human preadipocytes combined with a collagen sponge and gelatin
microspheres incorporating bFGF which can achieve the controlled release. The
controlled release technology with the microspheres enabled bFGF to enhance the
biological activities of preadipocytes proliferation and neovascularization into the
scaffold [15], resulting in promoted cells-induced adipose tissue regeneration.
The second way is to induce the in vivo formation of adipose tissues by making
use of the potentials of precursor or stem cells, like preadipocytes, originally present
in the body. If it is possible to provide the cells with a local environment suitable for
their proliferation and differentiation, de novo formation of adipose tissue will be
expected without exogenous transplantation of cells necessary for adipogenesis. De
novo adipogenesis in the mouse subcutis could be induced by the injection of mixed
bFGF and an extract of basement membrane of murine tumor cell line (Matrigel®)
[16]. Mixing with the Matrigel® promoted the angiogenic activity of bFGF [17],
which is essential for the generation and maintenance of adipose tissue. We have
succeeded in the controlled release of bFGF from gelatin hydrogels [18] and en-
hanced the angiogenic effect in vivo [19]. Following the subcutaneous implantation
of Matrigel® combined with the hydrogel for bFGF release into the mouse back,
significantly higher de novo adipogenesis at the implanted site was observed than
the implantation of mixed Matrigel® and free bFGF [20, 21]. In addition, we re-
ported that the implantation of collagen sponge alone into a natural adipose tissue
achieved successful the regeneration of adipose tissues in the collagen sponge [22].
It is highly conceivable that precursor cells are migrated into the collagen sponge
of suitable scaffold from the surrounding tissues, resulting in in situ regeneration
of adipose tissue. To this end, biomaterial design and preparation of scaffolds to
promote cell migration and proliferation or growth factor delivery have been exten-
sively tried [6, 23]. The idea is that biomaterials for cell scaffolds, space making
membranes, and growth factors delivery give cells a local environment necessary
for cell-induced tissue regeneration.
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This study is undertaken to obtain fundamental information about effect of the
biodegradability of collagen sponge scaffolds and the time profile of bFGF release
on adipose tissue regeneration. Although the in vivo degradability of scaffolds has
an important influence on successful tissue regeneration and replacement [24], little
has been reported about this issue. In addition, the time profile of bFGF release may
affect adipose tissue regeneration. In the present study, collagen sponges with differ-
ent rates of biodegradability were prepared by changing the cross-linking conditions
in sponge preparation, while the biodegradation profile of gelatin microspheres was
changed to alter the time profile of bFGF release. Following the subcutaneous im-
plantations of collagen sponges combined with human preadipocytes and the gelatin
microspheres incorporating bFGF into the back subcutis of nude mice, the histo-
logical area of adipose tissue newly formed was evaluated in terms of scaffolds
biodegradability and time profile of bFGF release.
2. Materials and Methods
2.1. Materials
An aqueous solution of human recombinant bFGF with an isoelectric point (IEP)
of 9.6 (10 mg/ml) was kindly supplied by Kaken Pharmaceutical (Tokyo, Japan).
Collagen solution (pH 3.0, 0.3 wt%) was kindly supplied by Nitta Gelatin (Osaka,
Japan). A gelatin sample with an IEP of 5.0 (Nitta Gelatin) was prepared through an
alkaline process of type I collagen obtained from the bovine bone. Glutaraldehyde
(GA), glycine and other chemicals were purchased from Wako (Osaka, Japan) and
used without further purification.
2.2. Preparation of Collagen Sponges
Type I bovine collagen solution (10 ml) was poured into an aluminum mold
(6 × 6 cm2) and frozen at −20◦C. Then, the samples were freeze-dried to obtain
porous sponges. The freeze-dried sponge was placed in a vacuum oven for dehy-
drothermal cross-linking of collagen (105◦C, 0.01 Torr, 24 h), and next immersed to
various concentrations of glutaraldehyde solution for various time periods (Table 1)
for chemical cross-linking at 4◦C. Then, the cross-linked sponges were immersed
in 100 mM glycine aqueous solution to block the residual aldehyde groups, and
washed with double distilled water (DDW) thoroughly. The resultant sponges were
freeze-dried again and sterilized by ethyleneoxide.
2.3. Preparation of Gelatin Microspheres Incorporating bFGF
Gelatin microspheres were prepared through the gelation of gelatin aqueous solu-
tion in an emulsion state, followed by the chemical cross-linking with glutaralde-
hyde solution in the dispersion state as reported previously [25]. Briefly, 10 ml
gelatin aqueous solution preheated at 45◦C was added drop-wise to 375 ml olive oil
under stirring at 420 rpm and 45◦C to obtain a w/o emulsion. Stirring was contin-
ued at 4◦C for 1 h to allow gelatin for gelation. After the addition of 100 ml acetone
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Table 1.
Preparation of cross-linked collagen sponges
Code Dehydrothermal cross-linking GA (wt%) Reaction time (h)
C1 + – –
C2 + 0.02 3
C3 + 0.02 24
C4 + 0.2 3
C5 + 0.2 24
Table 2.
Preparation of cross-linked gelatin microspheres




to the reaction mixture, the resulting microspheres were collected by centrifugation
(5000 rpm, 4◦C, 5 min) and washed 5 times with acetone by centrifugation.
The non-cross-linked and dried gelatin microspheres (500 mg) were placed in
0.1 wt% of Tween-80 aqueous solution containing different concentrations of GA
(Table 2, 100 ml) and stirred at 4◦C for 15 h to proceed their cross-linking. After
collecting by centrifugation (5000 rpm, 4◦C, 5 min), the microspheres were further
agitated in 100 ml of 100 mM glycine aqueous solution at 37◦C for 1 h to block the
residual aldehyde groups of untreated GA. The resulting microspheres were finally
washed with DDW, centrifuged at 5000 rpm for 5 min, and freeze-dried.
The original bFGF solution was diluted with DDW to adjust the solution concen-
tration to 50 µg/ml. The aqueous solution of bFGF (20 µl) was dropped onto 2 mg
freeze-dried gelatin microspheres, followed by leaving at 25◦C for 3 h for impreg-
nation of bFGF into the microspheres. The bFGF solution was completely absorbed
into the microspheres through the impregnation process because the solution vol-
ume was much less than that theoretically required for the equilibrated swelling
of microspheres. Our previous study indicated that the time periods of gelatin mi-
crospheres completely degraded in vivo were 1, 3 and 5 weeks for G1, G2 and G3
microspheres, respectively [26].
2.4. Evaluation of Collagen Sponges Biodegradability
All animal experiments were performed under permission from Animal Experiment
Committee of Institute for Frontier Medical Sciences, Kyoto University and fol-
lowed by the Guidelines for Animal Experiments of Institute for Frontier Medical
Sciences, Kyoto University.
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The in vivo degradation profile of collagen sponges was evaluated by the method
previously reported [27]. Briefly, 20 µl of phosphate-buffered saline (PBS, pH 7.4)
solution of [125I] Bolton–Hunter reagent (NEX120H, Perkin-Elmer, Waltham, MA,
USA) was homogeneously dropped onto collagen sponges (5 × 5 × 3 mm3) for
radiolabeling. After incubation of sponges at 4◦C for 3 h, the sponges were washed
with DDW at 4◦C thoroughly, then implanted into the back subcutis of female ddY
mice, 6 week-age (Shimizu Laboratory Supply, Kyoto, Japan). Remaining sponges
and tissues around the implantation site were obtained at different time intervals
and their radioactivity was counted by a gamma counter (ARC-360, Aloka, Tokyo,
Japan) to evaluate the biodegradation profile of collagen sponges.
2.5. Isolation and Culture of Human Preadipocytes
Isolation and culture of human preadipocytes were performed by the method pre-
viously reported [15]. Briefly, human preadipocytes were primarily isolated from
human adipose tissues that were obtained in the axillary lymph node dissection of
breast cancer patients with informed consent at Kyoto University Hospital. The adi-
pose tissue was washed with PBS to carefully remove blood cells, then minced, and
digested with 520 U/ml collagenase (Nitta Gelatin) with 20 mg/ml bovine serum
albumin (Nacalai Tesque, Kyoto, Japan) and a DMEM/F12 mixture (1:1, Sigma-
Aldrich, St. Louis, MO, USA) in a water bath at 37◦C for 30 min under shaking.
The digested was suspended in Medium 199 containing 10 vol% fetal bovine serum
(FBS), followed by centrifugation (1000 rpm, 4◦C, 5 min) to remove the super-
natant. After washed twice with the medium, the cells obtained were cultured in a
cell-culture flask (75 cm2, Corning 430720, 1000 cells/cm2) in the medium con-
taining 0.1 µg/ml bFGF at 37◦C and 5% CO2/95% air atmosphere pressure. The
cells were expanded and subjected to the following in vivo experiments. The mor-
phological feature of the cells was fibroblast-like. When the cells were cultured
in the presence of 50 nM insulin, 100 nM dexamethasone, 10 µg/ml transferrin and
200 pM triiodethyronine for 14 days, they accumulated fat droplets inside [15]. This
suggests that the cells isolated had an inherent nature to differentiate into matured
adipocytes.
2.6. Cell Attachment Test for Collagen Sponges
The cell compatibility of collagen sponges was evaluated by the initial cell attach-
ment of human preadipocytes based on the previous study [28]. Briefly, 500 µl of
a cell suspension (2 × 106 cells/ml) was poured in a polypropylene tube (2236-
012N, Iwaki Glass, Chiba, Japan). A collagen sponge (6 mm diameter, 3 mm
thickness) was placed in the cell suspension, followed by agitation with an orbital
shaker (Bellco Glass, Vineland, NJ, USA) at 300 rpm for 6 h. The cell-seeded col-
lagen sponges were thoroughly washed with PBS to exclude non-adherent cells.
The number of cells attached in collagen sponge was determined by the fluoro-
metric quantification assay of cellular DNA [29]. Briefly, cell-seeded sponges were
digested by the collagenase solution in a water bath at 37◦C for 30 min under shak-
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ing. The cells prepared were washed with PBS twice and stored at −20◦C until
assayed. After thawing, cells were lysed in 1 ml of a buffer solution (pH 7.4) con-
taining 0.2 mg/ml of sodium dodecyl sulfate and 30 mM sodium citrate-buffered
saline (SSC) with pipetting. The cell lysate (100 µl) was mixed with 400 µl of SSC
buffer. After mixing with 500 µl of a dye solution containing 30 mM SSC and
1 µg/ml Hoechst 33258 (Nacalai Tesque), the fluorescence intensity of the mixed
solution was measured with a fluorescence spectrometer (F-2000, Hitachi, Tokyo,
Japan) at excitation and emission wavelengths of 355 and 460 nm, respectively. The
percent cells attached was estimated from the calibration curve prepared by use of
known initial number of cells.
2.7. In Vivo Implantation
bFGF aqueous solution (20 µl, 0.05 mg/ml) was dropped onto 2 mg of freeze-dried
gelatin microspheres, followed by leaving at 25◦C for 3 h to obtain gelatin mi-
crospheres incorporating bFGF. The microspheres were mixed with the suspension
of human preadipocytes at a density of 1 × 105 cells/50 µl culture medium. The
mixed suspension was dropped on the freeze-dried collagen sponge (10 × 10 ×
3 mm3), followed by incubation at 37◦C for 3 h and 5% CO2/95% air atmosphere
pressure to obtain the collagen sponge combined with human preadipocytes and
gelatin microspheres incorporating bFGF. The cell density and bFGF dose were
selected as the optimal conditions based on the paper previously reported [15].
Under anesthesia, the collagen sponge incorporating human preadipocytes and
gelatin microspheres incorporating bFGF was carefully implanted into the back
subcutis of 6-weeks-old, female BALB/c nude mice, 1.5 cm apart from the tail
root at the body center where is free of originally existing adipose tissue. Each
experimental group was composed of 6 mice. Four weeks after implantation, the
mice were killed by an overdose injection of anesthetic and the skin including the
implanted site (2 × 2 cm2) was carefully taken off for the subsequent examinations.
2.8. Histological Analysis
De novo formation of adipose tissues at the implanted site was assessed in terms of
histological examination. The skin flap including implanted site was fixed with 10%
neutralized formalin solution, embedded in paraffin and sectioned (4 µm in thick-
ness) at the portion of implanted site as central as possible, followed by staining
with hematoxylin and eosin (HE).
Microphotographs of 6 cross-sections from 6 different mice were taken at a sim-
ilar magnification to evaluate the de novo formation of adipose tissue. The same
area of interest (3 portions/cross-section, 0.8×0.5 mm2) was randomly selected by
blind assessors with blinding the experimental groups indication and the area occu-
pied by matured adipocytes at the implanted site for every portion was measured to
express as the area of adipose tissue.
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Figure 1. In vivo degradation profiles of collagen sponges after implantation into the back subcutis of
mice: (!) C1, (P) C2, (1) C3, (") C4 and (Q) C5 sponges.
2.9. Statistical Analysis
All the data were analyzed by Fisher’s LSD test for multiple comparisons and the
statistical significance was accepted at P < 0.05. Experimental results were ex-
pressed as the mean + standard deviation of the mean (SD).
3. Results
Figure 1 shows the biodegradability of collagen sponges in mice subcutis. The
collagen sponges were radiolabeled with the Bolton–Hunter reagent and their
biodegradability was evaluated by counting the remaining radioactivity around the
implanted site after subcutaneous implantation. In the case of C1 sponges with-
out GA-cross-linking, the sponges disappeared three days after implantation. In
contrast, GA-cross-linked sponges were remained in the body for longer time pe-
riods, and the remaining time of radioactivity around the implanted sites changed
from 7 to 35 days. The degradation profile of collagen sponges could be controlled
by changing GA concentration and cross-linking time. The higher GA concentra-
tion and the longer treatment time, the longer time period the collagen sponges
remained.
Figure 2 shows the ratio of human preadipocytes attached into collagen sponges
6 h after orbital agitation with cell suspension. About 50% of the cells seeded was
attached into any collagen sponge. There was no significant difference in the cell
number ratio among all the groups.
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Figure 2. Number of cells attached to collagen sponges 6 h after agitation cell seeding.
Figure 3 shows the histological sections of C1–C5 collagen sponges combined
with human preadipocytes and G2 gelatin microspheres incorporating bFGF into
back subcutis of nude mice 4 weeks after implantation. Except for the C5 collagen
sponge group, matured adipocytes, which are indicated as white circular cells in
Fig. 3 and denoted ‘F’, were observed in every group at subcutaneous implanted
site, although the number depended on the group. Eosin-stained ribbon-like matri-
ces were observed at the implanted site of C4 and C5 collagen sponge implantation
groups.
Figure 4 shows the area of adipose tissues determined from the histological im-
age analysis 4 weeks after implantation of collagen sponges C1–C5 combined with
human preadipocytes and G2 gelatin microspheres incorporating bFGF. The highest
area of adipose tissues newly formed was observed for the collagen sponge with a
biodegradability of 2 weeks. If the biodegradation period was shorter than 2 weeks,
the cross-sectional area of adipose tissues newly formed was smaller. The area was
also smaller for the sponge with longer biodegradation time periods.
Figure 5 shows the histological sections at the implanted site of C3 collagen
sponges combined with human preadipocytes and gelatin microspheres G1–G3
incorporating bFGF. Matured adipocytes were observed in every group at subcu-
taneous implanted site. Figure 6 shows the area of adipose tissues determined from
the histological image analysis 4 weeks after implantation C3 collagen sponges
combined with human preadipocytes and gelatin microspheres G1–G3 incorporat-
ing bFGF. There was no significant difference in the cross-sectional area of adipose
tissues newly formed among the G1–G3 groups.
4. Discussion
We have evaluated the effect of sponge scaffold biodegradation and bFGF release
profiles on the de novo regeneration of adipose tissues. As a result, an optimal
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Figure 3. Histological cross-sections of C1, C2, C3, C4, C5 collagen sponges combined with human
preadipocytes and G2 gelatin microspheres incorporating bFGF 4 weeks after implantation into the
back subcutis of nude mice. F, matured adipocyte. This figure is published in colour in our online
edition, which can be accessed via http://www.brill.nl/jbs
degradation time of scaffolds was found for preadipocyte-induced regeneration
of adipose tissues. We have already reported that adipose tissue engineering was
achieved by the implantation of collagen sponge with human preadipocytes and re-
leasing system of bFGF. It is demonstrated that there was an optimal cell number
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Figure 4. Area of adipose tissues newly formed 4 weeks after implantation of C1, C2, C3, C4 and
C5 collagen sponges combined with human preadipocytes, and G2 gelatin microspheres incorporating
bFGF into the back subcutis of nude mice.
Figure 5. Histological cross-sections of C3 collagen sponges combined with human preadipocytes,
and G1, G2 and G3 gelatin microspheres incorporating bFGF 4 weeks after implantation into the back
subcutis of nude mice. F, matured adipocyte. This figure is published in colour in our online edition,
which can be accessed via http://www.brill.nl/jbs
and bFGF dose for de novo adipose tissue regeneration [15]. In this study, based on
the cell number and bFGF dose experimentally optimized by our previous paper,
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Figure 6. Area of adipose tissues newly formed 4 weeks after implantation of C3 collagen sponges
combined with human preadipocytes, and G1, G2 and G3 gelatin microspheres incorporating bFGF
into the back subcutis of nude mice.
we investigated the influence of collagen sponge biodegradability and the bFGF
release profile on the adipose tissue regeneration.
In the field of tissue engineering, many biomaterials have been used as a ma-
trix for cells scaffolds and bioactive molecules [30, 31]. The controlled release of
bioactive molecules is a key factor for the successful tissue regeneration [23, 32].
For the scaffold, many researches aim at the control of physical property [33, 34],
physical stiffness [35, 36] and in vivo biodegradation [36–39] to modify the cells’
behavior. Among them, the scaffold degradation was studied in the area of bone
substitute to achieve the proper contact with native bone tissue and prevent bone
absorption around the materials implanted. In the reports, it is concluded that the
faster degradation is preferred to bone tissue formation and the migration of vas-
cular endothelial cells. However, the effect of scaffold biodegradation on the soft
tissue regeneration is not investigated.
In this study, too fast and too slow degradation of collagen scaffolds resulted
in less formation of adipose tissues. We have reported in the previous paper that
4 weeks needed for the in vivo formation of adipose tissue [22] and the adipose tis-
sue formed was histologically retained until 6 weeks after implantation. We believe
that evaluation 4 weeks after the implantation suffices to evaluate the effect of the
time period of bFGF release and the biodegradability of collagen sponges on the in
vivo formation of adipose tissues.
In Fig. 2, no difference in the cell compatibility among the collagen sponges C1–
C5 under serum-containing cell-culture medium condition was observed. After the
GA cross-linking reaction of collagen sponges, the residual aldehyde groups of GA
were chemically blocked by the treatment of sponges with excess molar of glycine.
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Therefore, we believe that the GA concentration did not affect the cell attachment.
Some researches indicated that materials cross-linked with GA do not show any
toxic effects to cells even without any blocking reaction [40]. Based on this, we
could estimate the effect of sponge biodegradability alone on the adipose tissue
engineering.
The phenomenon that less regeneration was observed in fast degraded sponges
may be due the scaffolds property to make a space for tissue regeneration. The
scaffold plays two important roles in tissue regeneration. One is that it provides a
platform for cells to attach to and maintain life, and the other is providing space
for tissue regeneration. The latter has been clinically confirmed through the guided
tissue regeneration (GTR) application to dental surgery. The GTR membrane made
from non-biodegradable material was used for space-making and was effective for
prevention of scar tissue in-growth [41]. The fast degradation of scaffold could not
provide the space for growth and differentiation of preadipocytes.
On the other hand, the phenomenon that the slow degradation of collagen
sponges contributed to less adipose tissue regeneration may be due to physical
impairment of the tissue-regeneration process. The collagen sponge implanted is
basically not biologically natural, but foreign and artificial material, although it has
been reported to function as a scaffold suitable for the initial step of regeneration. It
is conceivable that the remaining in the site to be regenerated physically impairs the
natural process of tissue regeneration, resulting in less new formation of adipose tis-
sues. The balance of scaffold degradation is a key factor to induce cell-based tissue
regeneration.
There was no significant effect of bFGF release profiles after 1, 3 and 5 weeks
on the adipose tissue regeneration. We have demonstrated that gelatin microspheres
incorporating bFGF were effective in inducing de novo adipogenesis [15]. Implan-
tation of collagen sponges combined with human preadipocytes and gelatin mi-
crospheres for the controlled release of bFGF achieved significantly high amounts
of adipose tissue newly formed compared with the solution injection of bFGF at
a 10-times higher dose. Upon implanting with the collagen sponge incorporat-
ing either gelatin microspheres incorporating bFGF or human preadipocytes, and
the mixture of human preadipocytes and gelatin microspheres incorporating bFGF,
any particular change of tissue appearance was not observed at the implanted site.
This result indicated that every combination of two of three components, collagen
sponges, human preadipocytes and gelatin microspheres incorporating bFGF, did
not result in formation of adipose tissue [15]. Therefore, the combination of colla-
gen sponge, human preadipocytes and bFGF was indispensable for adipose tissue
regeneration, and the local environment which allows human preadipocytes to pro-
liferate and differentiate into matured adipocytes was provided by implantation of
the collagen sponge together with the release system of bFGF. bFGF is known as
a promoting factor of preadipocyte growth [16, 42], but its ability to induce adi-
pogenic differentiation of preadipocytes and other cells is controversial [43–45].
On the other hand, bFGF has a strong angiogenic activity in vivo [17, 19]. In this
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study, it is possible that bFGF released acts on the initial step of de novo adipoge-
nesis. The bFGF would induce angiogenesis and the proliferation of preadipocytes
implanted. As result, no significant difference in the adipose tissue regeneration
would be observed by prolonged bFGF release.
The present study clearly indicates importance of material design to achieve
the optimal regeneration of adipose tissues. As expected, the in vivo biodegrad-
ability of scaffolds greatly affected the regeneration, because the existence of cell
local environment undoubtedly modifies the cell behavior. In addition to the scaf-
fold biodegradability, the chemical composition and the combination of signaling
molecules must be important. This issue is presently under investigation in our lab-
oratory.
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